- Home
- EKSO vs MTNB Comparison
EKSO vs MTNB Comparison
Compare EKSO & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EKSO
- MTNB
- Stock Information
- Founded
- EKSO 2005
- MTNB 2013
- Country
- EKSO United States
- MTNB United States
- Employees
- EKSO N/A
- MTNB N/A
- Industry
- EKSO Medical/Dental Instruments
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- EKSO Health Care
- MTNB Health Care
- Exchange
- EKSO Nasdaq
- MTNB Nasdaq
- Market Cap
- EKSO 7.7M
- MTNB 7.9M
- IPO Year
- EKSO N/A
- MTNB N/A
- Fundamental
- Price
- EKSO $3.91
- MTNB $1.82
- Analyst Decision
- EKSO Strong Buy
- MTNB Hold
- Analyst Count
- EKSO 2
- MTNB 1
- Target Price
- EKSO $34.75
- MTNB N/A
- AVG Volume (30 Days)
- EKSO 47.8K
- MTNB 1.4M
- Earning Date
- EKSO 10-27-2025
- MTNB 08-14-2025
- Dividend Yield
- EKSO N/A
- MTNB N/A
- EPS Growth
- EKSO N/A
- MTNB N/A
- EPS
- EKSO N/A
- MTNB N/A
- Revenue
- EKSO $14,651,000.00
- MTNB N/A
- Revenue This Year
- EKSO N/A
- MTNB N/A
- Revenue Next Year
- EKSO $49.96
- MTNB N/A
- P/E Ratio
- EKSO N/A
- MTNB N/A
- Revenue Growth
- EKSO N/A
- MTNB N/A
- 52 Week Low
- EKSO $2.73
- MTNB $0.47
- 52 Week High
- EKSO $19.20
- MTNB $4.67
- Technical
- Relative Strength Index (RSI)
- EKSO 61.83
- MTNB 56.95
- Support Level
- EKSO $3.01
- MTNB $1.89
- Resistance Level
- EKSO $3.31
- MTNB $2.24
- Average True Range (ATR)
- EKSO 0.18
- MTNB 0.37
- MACD
- EKSO 0.10
- MTNB 0.01
- Stochastic Oscillator
- EKSO 100.00
- MTNB 27.84
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.